PMID: 6966323Apr 1, 1980Paper

A further prevalence study of multiple sclerosis in north-east Scotland

Journal of Neurology, Neurosurgery, and Psychiatry
D I Shepherd, A W Downie

Abstract

A second epidemiological study of multiple sclerosis (MS) in north-east Scotland has confirmed that the area has the highest prevalence rate in the world for any population of comparable size. On 1 December 1973 the prevalence was 144 per 100000 population. The age and sex specific prevalence rates are the highest ever recorded, one in every 306 of the population aged 40 to 59 years being affected. All patients have been tabulated in the National Health Service Central Register to facilitate future studies. The MS mortality rate in north-east Scotland is similar to the rate for the whole of Scotland. Throughout most of Scotland, therefore, MS probably is as prevalent as it is in the north-east.

References

Jul 29, 1978·British Medical Journal·D I Shepherd, A W Downie
Dec 1, 1972·Journal of the Neurological Sciences·W Cendrowski, J Majkowski
Aug 1, 1971·Archives of Neurology·A K PercyL T Kurland
Aug 1, 1966·Journal of Chronic Diseases·L Lasagna
Dec 1, 1956·Brain : a Journal of Neurology·J M SUTHERLAND
Jan 1, 1960·Acta Psychiatrica Scandinavica. Supplementum·F GEORGI, P HALL
Nov 19, 1959·The New England Journal of Medicine·W E DEACONL T KURLAND
Aug 1, 1963·Journal of Neurology, Neurosurgery, and Psychiatry·D C POSKANZERH MILLER

❮ Previous
Next ❯

Citations

Dec 1, 1994·Annals of Neurology·C M Poser
Mar 1, 1988·Journal of Neurology·H Meyer-Rienecker, F Buddenhagen
Jan 1, 1990·Irish Journal of Medical Science·D LordE Keelan
Dec 1, 1987·Journal of the Neurological Sciences·E J Field, G Joyce
Jan 1, 1990·The Science of the Total Environment·G W Lowis
Jan 6, 1992·Biochimica Et Biophysica Acta·A Andreadis, E R Rosenthal
Dec 1, 1996·Acta Neurologica Scandinavica·N Zilber, E Kahana
Jul 26, 1986·British Medical Journal·E S Williams, R O McKeran
Aug 10, 1991·BMJ : British Medical Journal·M J Lockyer
Mar 1, 1987·Journal of Epidemiology and Community Health·J G Phadke, A W Downie
Jun 1, 1996·Journal of Epidemiology and Community Health·N RobertsonD A Compston
Mar 18, 2004·Journal of Neurology, Neurosurgery, and Psychiatry·C McGuiganM Hutchinson
Oct 1, 1986·Journal of Neurology, Neurosurgery, and Psychiatry·R J Swingler, D Compston
Feb 1, 1987·Journal of Neurology, Neurosurgery, and Psychiatry·D C SkeggM Pollock
Mar 1, 1987·Journal of Neurology, Neurosurgery, and Psychiatry·M Elian, G Dean
Jan 1, 1991·Journal of Neurology, Neurosurgery, and Psychiatry·M H RobertsA J Spackman
Feb 1, 1991·Journal of Neurology, Neurosurgery, and Psychiatry·E S WilliamsR O McKeran
Oct 1, 1992·Journal of Neurology, Neurosurgery, and Psychiatry·C J MumfordD A Compston
Jan 1, 1995·Journal of Neurology, Neurosurgery, and Psychiatry·N Robertson, A Compston
Jan 1, 1995·Journal of Neurology, Neurosurgery, and Psychiatry·M Rice-OxleyJ E Rees
Jul 1, 1995·Journal of Neurology, Neurosurgery, and Psychiatry·N RobertsonD A Compston
Oct 1, 1996·Journal of Neurology, Neurosurgery, and Psychiatry·D I Shepherd, A Summers
May 23, 1998·Journal of Neurology, Neurosurgery, and Psychiatry·H L FordD R Williams
Jul 1, 1998·Journal of Neurology, Neurosurgery, and Psychiatry·P M Rothwell, D Charlton
Jan 19, 2007·Neuroepidemiology·Layla Jader
Aug 12, 2014·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·Claude M J Braun, Carl Roberge
Jan 1, 1987·International Rehabilitation Medicine·D T Wade, R L Hewer
Apr 20, 2010·Lancet Neurology·Nils Koch-Henriksen, Per Soelberg Sørensen
Aug 4, 2007·Journal of the Neurological Sciences·Robert C SergottUNKNOWN OCT in MS Expert Panel
Sep 1, 1997·Clinical Immunology and Immunopathology·D L JacobsonN M Graham
Jun 25, 2008·Multiple Sclerosis : Clinical and Laboratory Research·O M GrayS A Hawkins
Jan 1, 1984·Annals of the New York Academy of Sciences·W I McDonald
Oct 7, 2004·Scottish Medical Journal·S MurrayS J Womersley
Oct 1, 1993·Acta Neurologica Scandinavica·K GrossA E Kaasik
Aug 1, 1995·Developmental Medicine and Child Neurology·G F Cole, C A Stuart
Aug 1, 1984·Acta Neurologica Scandinavica·J P LarsenJ A Aarli
Aug 26, 1998·Scottish Medical Journal·R M GrantR L Sloan
Jan 1, 1985·Annals of Neurology·E GranieriV C Monetti

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Neurology, Neurosurgery, and Psychiatry
R J Swingler, D A Compston
Journal of Neurology, Neurosurgery, and Psychiatry
M Rice-OxleyJ E Rees
© 2021 Meta ULC. All rights reserved